(Q24200469)

21 October 2023

Emanuela Marras

series ordinal

2

author given names

Emanuela

author last names

Marras

1 reference

21 October 2023

Florian ME Wagenlehner

series ordinal

3

author given names

Florian M E

author last names

Wagenlehner

1 reference

21 October 2023

Vittorio Magri

series ordinal

4

author given names

Vittorio

author last names

Magri

1 reference

Cochrane Database of Systematic Reviews

21 October 2023

publication date

12 August 2013

0 references

published in

0 references

cites work

Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Antimicrobial treatment for chronic prostatitis as a means of defining the role of Ureaplasma urealyticum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Treatment of bacterial prostatitis. Comparison of cephalexin and minocycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Recurrent urinary tract infections in men. Characteristics and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Evaluation of prostatic massage in treatment of chronic prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Treatment of chronic bacterial prostatitis by local injection of antibiotics into prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Treatment of chronic prostatitis. Comparison of Minocycline and Doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Semen quality in patients with Chlamydia trachomatis genital infection treated concurrently with prulifloxacin and a phytotherapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Ceftazidime, An Open Randomized Comparison of 3 Dosages for Genitourinary Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Treatment of chronic bacterial prostatitis with temafloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Therapy of Recurrent Invasive Urinary-Tract Infections of Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Gatifloxacin treatment for chronic prostatitis: a prospective multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Fluoroquinolone treatment of chronic bacterial prostatitis: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Single-drug or combined antibacterial therapy in the treatment of patients with chronic prostatitis and Chlamydia trachomatis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Percutaneous suprapubic transvesical route: a new and comfortable method of intraprostatic injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Penetration of antimicrobial agents into the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Comparison of economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

HOW COMMON IS PROSTATITIS? A NATIONAL SURVEY OF PHYSICIAN VISITS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Prevalence of chronic prostatitis symptoms in a randomly surveyed adult population of urban-community-dwelling Nigerian males

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

National prevalence of urogenital pain and prostatitis-like symptoms in Australian men using the National Institutes of Health Chronic Prostatitis Symptoms Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Concentration of azithromycin in human prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

The prevalence of prostatitis-like symptoms in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Treatment of bacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Antibiotic therapy - rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Management of bacterial prostatitis: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Statistical considerations for confirmatory clinical trials for similar biotherapeutic products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Prevalence, diagnosis and treatment of prostatitis in Italy: a prospective urology outpatient practice study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Therapy for prostatitis, with emphasis on bacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Prevalence of and risk factors for prostatitis in African American men: the Flint Men's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

Epidemiology of prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

NIH consensus definition and classification of prostatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Perineal versus anal submucosal injection for drug administration in treatment of chronic prostatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Efficacy and safety of gatifloxacin for urinary tract infection in nonspecialized Korean urologic practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

1 reference

7 January 2021

Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

1 reference

7 January 2021

Azithromycin: 4.5- or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis--a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Metronidazole 1.5 gram dose for 7 or 14 days in the treatment of patients with chronic prostatitis caused by Trichomonas vaginalis: A randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021

Effect of metacycline treatment on non-acute prostatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009071.PUB2

7 January 2021